Global Therapeutics Initiates Trial Of Next Generation Drug-Eluting Stent Using RNA Therapeutic Agent To Treat Coronary Artery Disease
Medical News Today
11th November 2008
Global Therapeutics, a leading developer of innovative solutions for the cardiology market, today announced initiation of the world's first clinical trial of a drug eluting stent that uses an antisense RNA therapeutics agent aimed at silencing one of the genes (c-myc) responsible for causing arteries to reclose after stenting (restenosis).
11th November 2008
Global Therapeutics, a leading developer of innovative solutions for the cardiology market, today announced initiation of the world's first clinical trial of a drug eluting stent that uses an antisense RNA therapeutics agent aimed at silencing one of the genes (c-myc) responsible for causing arteries to reclose after stenting (restenosis).
Latest news:
1st December 2008 -
Researchers Learn That Some 'Good Cholesterol' Isn't Good Enough
1st December 2008 -
New NPS Patient Resource On Infective Endocarditis, Australia
28th November 2008 -
Opportunity to invest in a novel Acoustic Pressure Sensor for medical applications
27th November 2008 -
Medis And TomTec Launch Joint Cardiac Imaging And Analysis Product
27th November 2008 -
International Medical Team Announces Patient Results In Adult Stem Cell Clinical Study For Pulmonary Hypertension
26th November 2008 -
Why Does It Take So Long For A Correct Diagnosis Of Pulmonary Hypertension?
26th November 2008 -
Dramatic JUPITER Findings Fail To Sway Prescribing Behavior, Poll Shows
15th November 2008 -
Statement By Merck & Co., Inc., In Response To The FDA's Update Regarding A Safety Review On Bisphosphonates Including FOSAMAX®
14th November 2008 -
Arsenic May Increase Risks For Cardiovascular Disease At Current Epa-Regulated Drinking Water Standards
14th November 2008 -
High-Normal Phosphate Levels Linked To Early Atherosclerosis
